{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:54:33Z","timestamp":1649073273302},"reference-count":40,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ejphar.2007.02.002","type":"journal-article","created":{"date-parts":[[2007,2,17]],"date-time":"2007-02-17T12:03:27Z","timestamp":1171713807000},"page":"164-171","source":"Crossref","is-referenced-by-count":9,"title":["Involvement of central \u03b11- and \u03b12-adrenoceptors on cardiovascular responses to moxonidine"],"prefix":"10.1016","volume":"563","author":[{"given":"Thiago S.","family":"Moreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Takakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 V.","family":"Menani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Colombari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.02.002_bib1","first-page":"R1065","article-title":"Alpha 2-adrenoceptor-mediated inhibition of bulbospinal barosensitive cells of rat rostral medulla","volume":"265","author":"Allen","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuroscience.2004.07.042","article-title":"Activation of alpha2-adrenergic receptors into the lateral parabrachial nucleus enhances NaCl intake in rats","volume":"129","author":"Andrade","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.02.002_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroscience.2006.04.015","article-title":"Alpha2-adrenergic activation in the lateral parabrachial nucleus induces NaCl intake under conditions of systemic hyperosmolarity","volume":"142","author":"Andrade","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.02.002_bib4","first-page":"1426","article-title":"General pharmacology of the novel centrally acting antihypertensive agent moxonidine","volume":"38","author":"Armah","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2007.02.002_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00005344-198309000-00009","article-title":"Effects of intracisternal and intravenous alpha-methyldopa and clonidine on haemodynamics and baroreceptor\u2014heart rate reflex properties in conscious rabbits","volume":"5","author":"Badoer","year":"1983","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0079-6123(08)62003-8","article-title":"Basis for the naturally occurring activity of rostral ventrolateral medullary sympathoexcitatory neurons","volume":"81","author":"Barman","year":"1989","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.002_bib7","first-page":"232","article-title":"Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines","volume":"230","author":"Bousquet","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.002_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2003.09.011","article-title":"Moxonidine and central alpha2 adrenergic receptors in sodium intake","volume":"993","author":"de Oliveira","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.002_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.bjp.0706146","article-title":"Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist","volume":"145","author":"El-Ayoubi","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib10","first-page":"R1572","article-title":"The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla","volume":"273","author":"Ernsberger","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1527-3466.1993.tb00198.x","article-title":"Moxonidine: a second-generation central antihypertensive agent","volume":"11","author":"Ernsberger","year":"1993","journal-title":"Cardiovasc. Drug Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2007.02.002_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00877082","article-title":"A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist","volume":"8","author":"Ernsberger","year":"1994","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2007.02.002_bib13","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00004872-199715011-00002","article-title":"The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease","volume":"15","author":"Ernsberger","year":"1997","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2007.02.002_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-1838(98)00093-9","article-title":"Does a second generation of centrally acting antihypertensive drugs really exist?","volume":"72","author":"Feldman","year":"1998","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.ejphar.2007.02.002_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00005344-200402000-00022","article-title":"Moxonidine, an antihypertensive agent, is permissive to alpha1-adrenergic receptor pathway in the rat-tail artery","volume":"43","author":"George","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(91)90534-W","article-title":"Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area","volume":"195","author":"Gomez","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib17","first-page":"R1580","article-title":"Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites?","volume":"273","author":"Guyenet","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrn1902","article-title":"The sympathetic control of blood pressure","volume":"7","author":"Guyenet","year":"2006","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.ejphar.2007.02.002_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0079-6123(08)62002-6","article-title":"Sympathoexcitatory neurons of the rostroventrolateral medulla and the origin of the sympathetic vasomotor tone","volume":"81","author":"Guyenet","year":"1989","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.002_bib20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1152\/jn.2000.83.2.766","article-title":"Prototypical imidazoline-1 receptor ligand moxonidine activates alpha2-adrenoceptors in bulbospinal neurons of the RVL","volume":"83","author":"Hayar","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005344-199424001-00002","article-title":"Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla","volume":"24","author":"Haxhiu","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib22","first-page":"H273","article-title":"Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat","volume":"241","author":"Haywood","year":"1981","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00004872-199816040-00012","article-title":"Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetized rabbit","volume":"16","author":"Head","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2007.02.002_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10571-006-9109-x","article-title":"Centrally acting imidazolines stimulate vascular alpha 1A-adrenergic receptors in rat-tail artery","volume":"26","author":"Kennedy","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00005344-199308000-00022","article-title":"Sympathoinhibitory action of rilmenidine in conscious sinoaortically denervated rats","volume":"22","author":"Mayorov","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0361-9230(99)00059-3","article-title":"Central moxonidine on water and NaCl intake","volume":"49","author":"Menani","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2007.02.002_bib27","series-title":"New Trends in Brain Research","first-page":"95","article-title":"Role of central \u03b12-adrenergic\/imidazoline receptors in the control of thirst, sodium appetite and renal excretion","author":"Menani","year":"2006"},{"key":"10.1016\/j.ejphar.2007.02.002_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-8993(03)03322-5","article-title":"Central moxonidine on salivary gland blood flow and cardiovascular responses to pilocarpine","volume":"987","author":"Moreira","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.002_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.bjp.0705853","article-title":"Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension","volume":"142","author":"Moreira","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.fjc.0000211794.68152.04","article-title":"Antihypertensive responses elicited by central moxonidine in rats: possible role of nitric oxide","volume":"47","author":"Moreira","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(98)00726-2","article-title":"Effect of moxonidine on blood pressure and sympathetic tone in spontaneously hypertensive rats","volume":"362","author":"Nurminen","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1476-5381.1994.tb13195.x","article-title":"Sodium excretion following central administration of an I1 imidazoline receptor agonist, moxonidine","volume":"112","author":"Penner","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.84.1","article-title":"Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors","volume":"84","author":"Raasch","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005344-199007000-00003","article-title":"Central presynaptic alpha 2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine","volume":"16","author":"Schlicker","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.002_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-1838(98)00100-3","article-title":"Imidazoline receptor mediated natriuresis: central and\/or peripheral effect?","volume":"72","author":"Smyth","year":"1998","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.ejphar.2007.02.002_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1749-6632.1999.tb09378.x","article-title":"Peripheral and central imidazoline receptor-mediated natriuresis in the rat","volume":"881","author":"Smyth","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.02.002_bib37","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0028-3908(02)00307-6","article-title":"Nitric oxide discriminates the sites and mechanisms of action of centrally acting anti-hypertensive drugs in rabbits","volume":"43","author":"Sy","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.02.002_bib38","first-page":"1062","article-title":"Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anesthetized rats","volume":"244","author":"Tibirica","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.002_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-8993(00)02089-8","article-title":"Alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice","volume":"862","author":"Tolentino-Silva","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.002_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(95)00297-X","article-title":"Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine","volume":"282","author":"Urban","year":"1995","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907001768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907001768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T17:59:52Z","timestamp":1556128792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907001768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":40,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0014299907001768"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.02.002","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}